Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review. | Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review. Abdalla HM, Mahmoud AK, Khedr AE, Farina JM, Scalia IG, Abbas MT, Awad KA, Baba Ali N, Bismee NN, Attaripour Esfahani S, Javadi N, Pereyra M, Alsidawi S, Lester SJ, Ayoub C, Arsanjani R., Free PMC Article | 11/5/2024 |
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. | Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. Behera S, Belyeu JR, Chen X, Paulin LF, Nguyen NQH, Newman E, Mahmoud M, Menon VK, Qi Q, Joshi P, Marcovina S, Rossi M, Roller E, Han J, Onuchic V, Avery CL, Ballantyne CM, Rodriguez CJ, Kaplan RC, Muzny DM, Metcalf GA, Gibbs RA, Yu B, Boerwinkle E, Eberle MA, Sedlazeck FJ., Free PMC Article | 10/25/2024 |
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. | Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. Nurmohamed NS, Gaillard EL, Malkasian S, de Groot RJ, Ibrahim S, Bom MJ, Kaiser Y, Earls JP, Min JK, Kroon J, Planken RN, Danad I, van Rosendael AR, Choi AD, Stroes ESG, Knaapen P., Free PMC Article | 09/17/2024 |
Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study. | Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study. de Boer LM, Hutten BA, Tsimikas S, Yeang C, Zwinderman AH, Kroon J, Revers A, Kastelein JJP, Wiegman A. | 05/23/2024 |
Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease. | Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease. Amin N, Devasia T, Kamath SU, Paramasivam G, Shetty PN, Singh A, Prakash GNS., Free PMC Article | 05/13/2024 |
Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study. | Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study. Simistiras A, Georgiopoulos G, Delialis D, Mavraganis G, Oikonomou E, Maneta E, Loutos C, Evangelou E, Stamatelopoulos K. | 05/6/2024 |
Lipoprotein(a), platelet function and cardiovascular disease. | Lipoprotein(a), platelet function and cardiovascular disease. Bhatia HS, Becker RC, Leibundgut G, Patel M, Lacaze P, Tonkin A, Narula J, Tsimikas S., | 04/26/2024 |
Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes. | Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes. He J, Yang M, Song C, Zhang R, Yuan S, Li J, Dou K. | 04/1/2024 |
Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies. | Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies. Singh S, Baars DP, Aggarwal K, Desai R, Singh D, Pinto-Sietsma SJ. | 03/6/2024 |
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation. | Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation. Dzobo KE, Cupido AJ, Mol BM, Stiekema LCA, Versloot M, Winkelmeijer M, Peter J, Pennekamp AM, Havik SR, Vaz FM, van Weeghel M, Prange KHM, Levels JHM, de Winther MPJ, Tsimikas S, Groen AK, Stroes ESG, de Kleijn DPV, Kroon J., Free PMC Article | 02/24/2024 |
Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study. | Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA(2)DS(2)-VASc scores: a cross-sectional study. Kamili K, Zheng T, Luo C, Wang X, Tian G., Free PMC Article | 02/12/2024 |
The 10 essential questions regarding lipoprotein(a). | The 10 essential questions regarding lipoprotein(a). Kostner KM, Kostner GM. | 02/9/2024 |
Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. | Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. Rogers MA, Bartoli-Leonard F, Zheng KH, Small AM, Chen HY, Clift CL, Asano T, Kuraoka S, Blaser MC, Perez KA, Natarajan P, Yeang C, Stroes ESG, Tsimikas S, Engert JC, Thanassoulis G, O'Donnell CJ, Aikawa M, Singh SA, Aikawa E., | 02/7/2024 |
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. | Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. Ugovšek S, Rehberger Likozar A, Levstek T, Trebušak Podkrajšek K, Zupan J, Šebeštjen M., Free PMC Article | 01/31/2024 |
The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis. | The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis. Qiu Y, Hao W, Guo Y, Guo Q, Zhang Y, Liu X, Wang X, Nie S. | 01/27/2024 |
Dysregulation of the LPC-ATX-LPA axis in autoimmune hepatitis is associated with monocyte activation. | Dysregulation of the LPC-ATX-LPA axis in autoimmune hepatitis is associated with monocyte activation. Yang F, Fan X, Yang L. | 01/8/2024 |
Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions. | Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions. Lan NSR, Khan Z, Watts GF. | 12/21/2023 |
Concordance of a High Lipoprotein(a) Concentration Among Relatives. | Concordance of a High Lipoprotein(a) Concentration Among Relatives. Reeskamp LF, Tromp TR, Patel AP, Ibrahim S, Trinder M, Haidermota S, Hovingh GK, Stroes ESG, Natarajan P, Khera AV., Free PMC Article | 12/21/2023 |
Association Between Lipoprotein (a) and Risk of Atrial Fibrillation: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. | Association Between Lipoprotein (a) and Risk of Atrial Fibrillation: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. Singh S, Baars DP, Desai R, Singh D, Pinto-Sietsma SJ. | 12/20/2023 |
Association of lipoprotein(a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study. | Association of lipoprotein(a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study. Yan X, Gong J, Wang Z, Wang F, Qi C., Free PMC Article | 12/20/2023 |
Association of Lipoprotein(a) Levels With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis. | Association of Lipoprotein(a) Levels With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis. Chehab O, Abdollahi A, Whelton SP, Wu CO, Ambale-Venkatesh B, Post WS, Bluemke DA, Tsai MY, Lima JAC. | 12/18/2023 |
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events. | Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events. Thomas PE, Vedel-Krogh S, Nielsen SF, Nordestgaard BG, Kamstrup PR. | 12/18/2023 |
Association of the LPA gene polymorphisms with coronary artery disease risk in the Xinjiang population of China: A case-control study. | Association of the LPA gene polymorphisms with coronary artery disease risk in the Xinjiang population of China: A case-control study. Liu YW, Dong CL, Jiang X, Liu DY., Free PMC Article | 12/6/2023 |
Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort. | Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort. Ghavami M, Abdshah A, Esteghamati S, Hafezi-Nejad N, Nakhjavani M, Esteghamati A., Free PMC Article | 12/5/2023 |
Association between lipoprotein(a) and insulin resistance in Chinese adults: results from the China health and nutrition survey. | Association between lipoprotein(a) and insulin resistance in Chinese adults: results from the China health and nutrition survey. Wang H, Fan JL., Free PMC Article | 12/3/2023 |